In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
Active, not recruiting · NCT04616248 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Tumor Virus Infections, adenocarcinoma, basal cell carcinoma, basal cell neoplasm, bone disorder, bone sarcoma, breast disorder, breast neoplasm, carcinoma, connective tissue neoplasm, cutaneous neuroendocrine carcinoma, epithelial neoplasm, melanocytic neoplasm, melanoma, metastatic melanoma, musculoskeletal system disorder, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, osteosarcoma, polyomavirus infectious disease, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, skin squamous cell carcinoma, viral infectious disease | Active, not recruiting | Phase 1 | 2026-06-18 | NCT04616248 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institutes of Health (NIH) | 667 |
| University of Southern California | 216 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Los Angeles General Medical Center | Los Angeles | United States | 179 |
| USC/Norris Comprehensive Cancer Center | Los Angeles | United States | 35 |